Clarification

The article "Trying To Unlock The Mysteries Of Free Radicals And Antioxidants" (A. Mack, The Scientist, Sept. 30, 1996, page 13) included an incorrect description of findings by researchers at Eukarion Inc. in Bedford, Mass., and the University of Southern California. The researchers demonstrated (A.J. Bruce et al., Proceedings of the National Academy of Sciences, 93:2312-6, 1996) that EUK-8-a chemical mimic of the active site of Mn SOD, the mitochondrial form of the enzyme superoxide dismutase

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article "Trying To Unlock The Mysteries Of Free Radicals And Antioxidants" (A. Mack, The Scientist, Sept. 30, 1996, page 13) included an incorrect description of findings by researchers at Eukarion Inc. in Bedford, Mass., and the University of Southern California. The researchers demonstrated (A.J. Bruce et al., Proceedings of the National Academy of Sciences, 93:2312-6, 1996) that EUK-8-a chemical mimic of the active site of Mn SOD, the mitochondrial form of the enzyme superoxide dismutase-protects neuronal tissue against beta-amyloid toxicity.

The article also gave incorrect information on free radical biology funding from the National Institute on Aging (NIA). NIA spent approximately $71 million, or 15 percent of its 1995-96 budget of $480 million, to support research on oxidative damage related to aging.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies